Structures by: Yathirajan H. S.
Total: 746
1-(3,5-dinitrobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H18N4O6
IUCrData (2020) 5, 11 x201523
a=25.348(2)Å b=7.3059(5)Å c=19.3470(10)Å
α=90° β=94.190(6)° γ=90°
Methyl 1-methyl-1<i>H</i>-indole-3-carboxylate
C11H11NO2
IUCrData (2018) 3, 12 x181728
a=8.3019(17)Å b=16.628(3)Å c=6.7622(14)Å
α=90° β=90° γ=90°
(<i>Z</i>)-1-benzoyl-5-benzylidene-2-hydroxy-4-oxo-4,5-dihydro-1<i>H</i>-pyrrole-3-carbonitrile
C19H12N2O3
IUCrData (2019) 4, 2 x190220
a=10.432(2)Å b=11.297(2)Å c=12.688(2)Å
α=90° β=90° γ=90°
Ethyl 2-(3,5-difluorophenyl)quinoline-4-carboxylate
C18H13F2NO2
IUCrData (2016) 1, 5 x160739
a=8.9998(8)Å b=9.0314(6)Å c=10.2747(5)Å
α=67.15(2)° β=72.45(3)° γ=82.91(3)°
Ethyl 4-(4-hydroxyphenyl) -6-(6-methoxy-2-naphthyl)-2-oxocyclohex -3-ene-1-carboxylate
C26H24O5
Crystals (2012) 2, 3 1239-1247
a=25.4114(5)Å b=8.47440(10)Å c=20.6921(4)Å
α=90.00° β=108.328(2)° γ=90.00°
C15H15NOS
C15H15NOS
Crystals (2012) 2, 3 1058-1066
a=9.2080(4)Å b=14.0485(7)Å c=10.3826(6)Å
α=90.00° β=90.00° γ=90.00°
C13H12ClNOS
C13H12ClNOS
Crystals (2012) 2, 3 1058-1066
a=10.3738(7)Å b=10.8501(7)Å c=11.8301(9)Å
α=90.00° β=98.615(7)° γ=90.00°
C13H12ClNOS
C13H12ClNOS
Crystals (2012) 2, 3 1058-1066
a=10.6092(8)Å b=10.8355(8)Å c=11.1346(9)Å
α=90.00° β=98.643(6)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.6941(6)Å b=10.7909(4)Å c=8.6586(3)Å
α=90.00° β=102.184(4)° γ=90.00°
3,5-bis(4-fluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide
C16H13F2N3S
Crystals (2012) 2, 3 1108-1115
a=14.339(2)Å b=11.1478(17)Å c=9.541(2)Å
α=90.00° β=107.007(18)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.5187(8)Å b=10.9358(5)Å c=8.8141(4)Å
α=90.00° β=101.245(5)° γ=90.00°
3,5-bis(4-fluorophenyl)-4,5-dihydro-1H-pyrazole-1-carboxamide
C16H13F2N3O
Crystals (2012) 2, 3 1108-1115
a=17.6219(6)Å b=10.8735(3)Å c=15.3216(5)Å
α=90.00° β=102.864(3)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.1766(19)Å b=11.2809(14)Å c=8.9334(14)Å
α=90.00° β=98.726(13)° γ=90.00°
C21H16F2O3
C21H16F2O3
CrystEngComm (2013) 15, 46 9893
a=6.9778(3)Å b=11.1289(5)Å c=11.5383(5)Å
α=96.213(3)° β=98.252(4)° γ=93.542(4)°
C19H12F2O3
C19H12F2O3
CrystEngComm (2013) 15, 46 9893
a=13.4533(5)Å b=9.8330(4)Å c=22.8428(9)Å
α=90.00° β=93.222(5)° γ=90.00°
C21H16F2O3
C21H16F2O3
CrystEngComm (2013) 15, 46 9893
a=7.3019(6)Å b=10.2526(9)Å c=13.0430(10)Å
α=94.613(7)° β=103.996(7)° γ=110.709(8)°
C19H14F2N2O2
C19H14F2N2O2
CrystEngComm (2013) 15, 46 9893
a=5.6775(3)Å b=30.6798(9)Å c=9.5451(4)Å
α=90.00° β=105.898(4)° γ=90.00°
2-Methyl-4-[(thiophen-2-yl)methylidene]-1,3-oxazol-5(4<i>H</i>)-one
C9H7NO2S
Acta Crystallographica Section C (2015) 71, 8
a=12.2264(11)Å b=9.8581(7)Å c=15.8735(13)Å
α=90° β=112.129(10)° γ=90°
4-Benzylidene-2-(4-methylphenyl)-1,3-oxazol-5(4<i>H</i>)-one
C17H13NO2
Acta Crystallographica Section C (2015) 71, 8
a=7.9940(4)Å b=9.0648(4)Å c=10.7692(6)Å
α=109.136(4)° β=109.397(4)° γ=97.320(4)°
3-Anilino-2-phenyl-5-[(thiophen-2-yl)methylidene]-3,5-dihydro-4<i>H</i>-imidazol-4-one
C20H15N3OS
Acta Crystallographica Section C (2015) 71, 8
a=8.8460(2)Å b=9.9951(2)Å c=11.2435(2)Å
α=114.4810(10)° β=98.5640(10)° γ=105.8910(10)°
3-Anilino-2-(4-methylphenyl)-5-[(thiophen-2-yl)methylidene]-3,5-dihydro-4<i>H</i>-imidazol-4-one
C21H17N3OS
Acta Crystallographica Section C (2015) 71, 8
a=9.1697(5)Å b=10.7939(5)Å c=11.0837(6)Å
α=66.424(2)° β=66.147(3)° γ=67.934(2)°
2-Phenyl-5-[(thiophen-2-yl)methylidene]-3-{[(<i>E</i>)-(thiophen-2-yl)methylidene]amino}-3,5-dihydro-4<i>H</i>-imidazol-4-one
C19H13N3OS2
Acta Crystallographica Section C (2015) 71, 8
a=8.2717(2)Å b=17.4530(3)Å c=23.3501(5)Å
α=90° β=90° γ=90°
Methyl (2<i>Z</i>)-2-(benzoylamino)-3-(thiophen-2-yl)prop-2-enoate
C15H13NO3S
Acta Crystallographica Section C (2015) 71, 8
a=16.6123(3)Å b=9.7589(2)Å c=17.7543(4)Å
α=90° β=90° γ=90°
Ethyl 4''-bromo-4-fluoro-5'-hydroxy-1,1':3',1''-terphenyl-4'-carboxylate
C21H16BrFO3
Acta Crystallographica Section C (2015) 71, 7
a=10.0725(3)Å b=12.5793(3)Å c=14.9438(4)Å
α=104.3320(10)° β=92.4670(10)° γ=94.5650(10)°
<i>N</i>-(3-Benzoyl-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-2-yl)-3-fluorobenzamide
C22H18FNO2S
Acta Crystallographica Section C (2018) 74, 1 45-53
a=15.9489(11)Å b=7.2739(4)Å c=15.9222(10)Å
α=90° β=95.813(4)° γ=90°
<i>N</i>-(3-Benzoyl-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-2-yl)-4-chlorobenzamide
C22H18ClNO2S
Acta Crystallographica Section C (2018) 74, 1 45-53
a=11.6776(6)Å b=14.2461(8)Å c=12.2957(7)Å
α=90° β=109.336(2)° γ=90°
2-Amino-3-benzoyl-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene
C15H15NOS
Acta Crystallographica Section C (2018) 74, 1 45-53
a=9.2080(4)Å b=14.0485(7)Å c=10.3826(6)Å
α=90° β=90° γ=90°
<i>N</i>-(3-Benzoyl-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-2-yl)-2,6-difluorobenzamide
C22H17F2NO2S
Acta Crystallographica Section C (2018) 74, 1 45-53
a=7.6718(3)Å b=9.8833(3)Å c=13.5925(5)Å
α=104.925(4)° β=95.476(2)° γ=103.633(3)°
<i>N</i>-(3-Benzoyl-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-2-yl)-2-methoxybenzamide
C23H21NO3S
Acta Crystallographica Section C (2018) 74, 1 45-53
a=8.5129(9)Å b=12.9230(14)Å c=19.031(2)Å
α=96.811(5)° β=102.665(6)° γ=105.321(5)°
<i>N</i>-[3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl]benzamide
C20H16ClNO2S
Acta Crystallographica Section C (2018) 74, 2
a=9.7868(9)Å b=13.9567(12)Å c=13.3764(11)Å
α=90° β=101.816(2)° γ=90°
<i>N</i>-[3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl]-4-phenylbenzamide
C26H20ClNO2S
Acta Crystallographica Section C (2018) 74, 2
a=10.7264(6)Å b=9.1208(5)Å c=22.9103(15)Å
α=90° β=94.414(2)° γ=90°
2-Bromo-<i>N</i>-[3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl]benzamide
C20H15BrClNO2S
Acta Crystallographica Section C (2018) 74, 2
a=18.8096(10)Å b=11.5021(7)Å c=19.9112(11)Å
α=90° β=118.030(2)° γ=90°
<i>N</i>-[3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl]-2-methoxybenzamide
C21H18ClNO3S
Acta Crystallographica Section C (2018) 74, 2
a=7.4798(3)Å b=11.4237(5)Å c=12.0933(5)Å
α=105.814(2)° β=101.959(3)° γ=99.187(3)°
<i>N</i>-[3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl]-2-iodobenzamide
C20H15ClINO2S
Acta Crystallographica Section C (2018) 74, 2
a=8.1813(6)Å b=11.8276(7)Å c=20.1347(12)Å
α=90° β=94.388(2)° γ=90°
Benzotriazol-1-yl 3,4-dimethoxybenzoate
C15H13N3O4
Acta Crystallographica Section C (2018) 74, 2
a=8.1296(6)Å b=9.5899(6)Å c=10.8824(8)Å
α=66.840(4)° β=71.533(4)° γ=71.350(4)°
<i>N</i>-[3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl]-2,6-difluorobenzamide
C20H14ClF2NO2S
Acta Crystallographica Section C (2018) 74, 2
a=58.0164(10)Å b=7.8002(2)Å c=16.1365(3)Å
α=90° β=92.1050(10)° γ=90°
5-(2-Chlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C17H13ClN2O2
Acta Crystallographica Section C (2019) 75, 6
a=10.3034(4)Å b=11.4856(4)Å c=14.4725(5)Å
α=81.013(2)° β=69.861(2)° γ=69.990(2)°
3-Methyl-5-(naphthalen-2-yloxy)-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C21H16N2O2
Acta Crystallographica Section C (2019) 75, 6
a=7.7302(6)Å b=17.2550(16)Å c=13.1989(11)Å
α=90° β=106.079(2)° γ=90°
3-Methyl-5-(4-nitrophenoxy)-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C17H13N3O4
Acta Crystallographica Section C (2019) 75, 6
a=14.1163(9)Å b=11.7268(7)Å c=9.3982(5)Å
α=90° β=94.259(3)° γ=90°
3-Methyl-1-phenyl-5-(piperidin-1-yl)-1<i>H</i>-pyrazole-4-carbaldehyde
C16H19N3O
Acta Crystallographica Section C (2019) 75, 6
a=8.9432(7)Å b=16.0546(14)Å c=10.1155(8)Å
α=90° β=97.777(2)° γ=90°
(3<i>RS</i>)-2-Acetyl-5-(4-azidophenyl)-5'-(2-chlorophenoxy)-3'-methyl-1'-phenyl-3,4-dihydro-1'<i>H</i>,2<i>H</i>-[3,4'-bipyrazole]
C27H22ClN7O2
Acta Crystallographica Section C (2019) 75, 6
a=10.8804(4)Å b=11.3363(4)Å c=11.5737(4)Å
α=97.294(2)° β=90.050(2)° γ=117.840(2)°
(3<i>RS</i>)-2-Acetyl-5-(4-azidophenyl)-3'-methyl-5'-(naphthalen-2-yloxy)-1'-phenyl-3,4-dihydro-1'<i>H</i>,2<i>H</i>-[3,4'-bipyrazole]
C31H25N7O2
Acta Crystallographica Section C (2019) 75, 6
a=10.4911(11)Å b=11.2048(12)Å c=13.5943(17)Å
α=105.323(3)° β=93.505(3)° γ=117.460(3)°
(<i>E</i>)-4-Bromo-2-[(2-hydroxyphenylimino)methyl]-6-methoxyphenol
C14H12BrNO3
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=13.297(2)Å b=15.095(3)Å c=6.4166(13)Å
α=90° β=91.329(6)° γ=90°
(<i>E</i>)-4-Bromo-2-methoxy-6-[(2-methoxyphenylimino)methyl]phenol
C15H14BrNO3
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=6.4158(3)Å b=7.3886(4)Å c=15.2636(7)Å
α=87.081(3)° β=87.488(3)° γ=77.948(3)°
(<i>E</i>)-<i>N</i>-(3,4-Dimethylisoxazol-5-yl)-4-[(2-hydroxybenzylidene)amino]benzenesulfonamide
C18H17N3O4S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=20.344(2)Å b=9.6384(9)Å c=9.4430(10)Å
α=90° β=101.060(3)° γ=90°
(<i>E</i>)-4-[(5-Bromo-2-hydroxy-3-methoxybenzylidene)amino]-<i>N</i>-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
C19H18BrN3O5S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=13.6043(11)Å b=12.2399(7)Å c=12.9506(9)Å
α=90° β=103.854(2)° γ=90°
(<i>E</i>)-2-Methoxy-6-[(2-methoxyphenylimino)methyl]phenol
C15H15NO3
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=23.689(2)Å b=7.6951(7)Å c=7.3488(7)Å
α=90° β=90° γ=90°
(<i>E</i>)-3-Benzoyl-2-[(2-hydroxybenzylidene)amino)]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene
C22H19NO2S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=9.26395(15)Å b=14.2886(2)Å c=13.6476(2)Å
α=90° β=96.7581(15)° γ=90°
(<i>E</i>)-3-Benzoyl-2-[(5-fluoro-2-hydroxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene
C22H18FNO2S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=9.5004(8)Å b=14.2911(11)Å c=13.6497(9)Å
α=90° β=97.524(2)° γ=90°
(<i>E</i>)-[(2-Hydroxyphenylimino)methyl]phenol
C13H11NO2
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=9.0479(7)Å b=10.1564(8)Å c=12.3659(10)Å
α=69.677(6)° β=89.940(6)° γ=77.004(6)°
\ 1-(3-methylphenyl)-5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-\ 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine
C22H22F3N3O2S
Acta Crystallographica Section C (2017) 73, 3 298-304
a=13.8408(10)Å b=8.7145(6)Å c=18.0898(13)Å
α=90° β=106.470(2)° γ=90°
3-(4-Fluorophenyl)-1-(naphthalen-2-yl)prop-2-en-1-one
C19H13FO
Acta Crystallographica Section C (2017) 73, 2 115-120
a=7.6678(4)Å b=11.5007(5)Å c=15.7874(8)Å
α=96.249(3)° β=96.752(3)° γ=90.796(3)°
3-(4-Bromophenyl)-1-(naphthalen-2-yl)prop-2-en-1-one
C19H13BrO
Acta Crystallographica Section C (2017) 73, 2 115-120
a=5.8714(5)Å b=7.8616(7)Å c=15.5954(13)Å
α=95.007(5)° β=90.218(5)° γ=92.179(5)°
1-(Naphthalen-2-yl)-3-(thiophen-2-yl)prop-2-en-1-one
C17H12OS
Acta Crystallographica Section C (2017) 73, 2 115-120
a=5.8271(3)Å b=7.4489(4)Å c=15.2068(9)Å
α=79.745(3)° β=84.427(3)° γ=85.763(3)°
1-(4-Chlorophenyl)-5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine
C21H19ClF3N3O2S
Acta Crystallographica Section C (2017) 73, 3 298-304
a=5.4468(2)Å b=11.4102(4)Å c=34.3009(9)Å
α=90° β=90° γ=90°
1-(4-Fluorophenyl)-5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine
C21H19F4N3O2S
Acta Crystallographica Section C (2017) 73, 3 298-304
a=19.7282(6)Å b=9.7644(3)Å c=20.7157(7)Å
α=90° β=90° γ=90°
2-(4-Chlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)acetamide
C19H18ClN3O2
Acta Crystallographica Section C (2016) 72, 9
a=10.1018(4)Å b=10.6099(5)Å c=18.8129(11)Å
α=100.292(3)° β=91.881(3)° γ=116.873(2)°
4-Amino-<i>N</i>-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide--3,5-dinitrobenzoic acid (1/1)
C11H13N3O3S,C7H4N2O6
Acta Crystallographica Section C (2016) 72, 8
a=7.8189(4)Å b=8.6727(5)Å c=15.9304(10)Å
α=96.439(5)° β=94.458(5)° γ=107.477(5)°
3-(4-Fluorophenyl)-1<i>H</i>-pyrazolium 2,4,6-trinitrophenolate
C9H8FN2,C6H2N3O7
Acta Crystallographica Section C (2016) 72, 8
a=11.8062(7)Å b=8.0061(4)Å c=17.6442(12)Å
α=90° β=107.009(7)° γ=90°
3-Amino-1<i>H</i>-pyrazol-2-ium 3,5-dinitrobenzoate monohydrate
C7H3N2O6,C3H6N3,H2O
Acta Crystallographica Section E (2021) 77, 1 34-41
a=6.6864(7)Å b=8.1857(9)Å c=12.6490(10)Å
α=79.424(9)° β=85.583(9)° γ=75.586(9)°
Bis(3-amino-1<i>H</i>-pyrazol-2-ium) fumarate—–fumaric acid (1/1) 2C~3~H~6~N~3~^+^\χdotC~4~H~2~O~4~^2-^\χdotC~4~H~4~O~4~, (II). The reaction of 3-amino-1<i>H</i>-pyrazole with a dilute solution of nitric acid in methanol yields an second, orthorhombic polymorph of 3-amino-1<i>H</i>-pyrazol-2-ium nitrate, C~3~H~6~N~3~^+^\χdotNO~3~^-^
2(C3H6N3),C4H2O42,C4H4O4
Acta Crystallographica Section E (2021) 77, 1 34-41
a=8.5410(4)Å b=14.0507(7)Å c=7.5137(4)Å
α=90° β=98.827(6)° γ=90°
3-Amino-1<i>H</i>-pyrazol-2-ium nitrate
C3H6N3,NO3
Acta Crystallographica Section E (2021) 77, 1 34-41
a=7.2700(10)Å b=9.907(2)Å c=8.551(2)Å
α=90° β=90° γ=90°
1-(4-Fluorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.3286(6)Å b=11.3388(7)Å c=20.3040(10)Å
α=90° β=90° γ=90°
1-(4-Iodobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=10.9626(5)Å b=11.3258(6)Å c=14.8234(7)Å
α=90° β=104.520(5)° γ=90°
1-(4-Chlorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19ClN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=29.7690(10)Å b=11.3173(4)Å c=20.4028(8)Å
α=90° β=90° γ=90°
1-(2-Fluorobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.4510(10)Å b=11.199(3)Å c=19.138(5)Å
α=90° β=99.59(2)° γ=90°
1-(4-Bromobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19BrN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=15.0779(7)Å b=11.2868(6)Å c=20.5297(9)Å
α=90° β=90° γ=90°
1-(3-Iodobenzoyl)-4-(2-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2021) 77, 1 5-13
a=7.4528(4)Å b=17.1306(9)Å c=27.9030(10)Å
α=90° β=90° γ=90°
Diethyl (<i>RS</i>)-2-[(4-chlorophenyl)(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)methyl]propanedioate
C24H25ClN2O5
Acta Crystallographica Section E (2020) 76, 10 1605-1610
a=13.5609(8)Å b=20.2800(10)Å c=17.7280(10)Å
α=90° β=95.363(5)° γ=90°
Diethyl (<i>RS</i>)-2-[(4-bromophenyl)(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)methyl]propanedioate
C24H25BrN2O5
Acta Crystallographica Section E (2020) 76, 10 1605-1610
a=13.5644(5)Å b=20.3405(7)Å c=17.4818(8)Å
α=90° β=94.858(4)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 4-chlorobenzoate
C11H17N2O,C7H4ClO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4010(10)Å b=7.8880(10)Å c=15.410(3)Å
α=100.28(2)° β=94.400(10)° γ=94.140(10)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-bromobenzoate
C11H17N2O,C7H4BrO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4313(5)Å b=7.9163(5)Å c=15.5212(9)Å
α=101.565(5)° β=94.780(5)° γ=92.691(5)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-iodobenzoate
C11H17N2O,C7H4IO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.1129(4)Å b=11.2722(7)Å c=12.5923(8)Å
α=69.852(5)° β=74.681(5)° γ=79.121(5)°
4-(2-Methoxyphenyl)piperazin-1-ium 2-fluorobenzoate
C11H17N2O,C7H4FO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=19.9400(10)Å b=10.2705(7)Å c=9.0148(7)Å
α=90° β=109.663(8)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-chlorobenzoate
C11H17N2O,C7H4ClO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.9974(8)Å b=27.611(2)Å c=8.5972(9)Å
α=90° β=106.400(10)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-bromobenzoate
C11H17N2O,C7H4BrO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=6.9824(2)Å b=13.2292(4)Å c=19.4903(7)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-iodobenzoate
C11H17N2O,C7H4IO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.0101(4)Å b=13.3796(6)Å c=19.5524(6)Å
α=90° β=90° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 2-methylbenzoate
C11H17N2O,C8H7O2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8260(10)Å b=10.320(2)Å c=12.055(3)Å
α=78.37(2)° β=78.27(2)° γ=73.83(2)°
4-(2-Methoxyphenyl)piperazin-1-ium 4-aminobenzoate
C11H17N2O,C7H6NO2
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=14.9220(10)Å b=7.6951(5)Å c=15.5600(10)Å
α=90° β=106.911(8)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 4-nitrobenzoate
C11H17N2O,C7H4NO4
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.5174(5)Å b=7.9761(5)Å c=29.860(2)Å
α=90° β=97.322(6)° γ=90°
4-(2-Methoxyphenyl)piperazin-1-ium 3,5-dinitrobenzoate dihydrate
C11H17N2O,C7H3N2O6,2(H2O)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8448(6)Å b=11.4635(9)Å c=12.0747(9)Å
α=94.406(7)° β=105.075(8)° γ=93.717(7)°
4-(2-Methoxyphenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C11H17N2O,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=9.4151(5)Å b=9.8721(5)Å c=10.9572(5)Å
α=77.524(4)° β=81.360(5)° γ=81.002(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen fumarate
C11H17N2O,0.5(C4H3O4),C1.14H0.86O1.14,C0.86H0.64O0.86)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8546(4)Å b=8.9626(6)Å c=11.2056(8)Å
α=79.043(5)° β=87.715(5)° γ=85.840(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen maleate
C11H17N2O,C4H3O4
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=11.1076(6)Å b=11.1164(6)Å c=13.7649(7)Å
α=80.353(5)° β=78.353(5)° γ=74.406(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen (2<i>R</i>,3<i>R</i>)-tartrate 1.698-hydrate
C11H17N2O,C4H5O6,1.698(H2O)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.4790(10)Å b=7.0650(10)Å c=17.788(3)Å
α=90° β=101.58(2)° γ=90°
Clozapinium hydrogen bis(3,5-dinitrobenzoate)
C18H20ClN4,C7H3N2O6,C7H4N2O6
Acta Crystallographica Section E (2020) 76, 10 1629-1633
a=7.4102(6)Å b=24.629(2)Å c=18.4460(10)Å
α=90° β=98.478(6)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium 2-bromobenzoate 0.353-hydrate
C10H14FN2,C7H4BrO2,0.353(H2O)
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=7.2584(8)Å b=9.3470(10)Å c=13.767(2)Å
α=101.140(10)° β=95.980(10)° γ=109.440(10)°
4-(4-Fluorophenyl)piperazin-1-ium 2-fluorobenzoate monohydrate
C10H14FN2,C7H4FO2,H2O
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=6.5873(5)Å b=7.6616(6)Å c=17.3399(9)Å
α=97.842(6)° β=90.378(6)° γ=95.540(6)°
4-(4-Fluorophenyl)piperazin-1-ium 2-iodobenzoate
C10H14FN2,C7H4IO2
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=9.8892(3)Å b=11.6831(7)Å c=16.4547(9)Å
α=106.776(5)° β=93.327(4)° γ=104.874(4)°
4-(4-Fluorophenyl)piperazin-1-ium 2,4,6-trinitrophenolate
C10H14FN2,C6H2N3O7
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=16.658(2)Å b=6.6734(6)Å c=17.553(3)Å
α=90° β=117.84(2)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium 3,5-dinitrobenzoate
C10H14FN2,C7H3N2O6
Acta Crystallographica Section E (2020) 76, 8 1179-1186
a=19.8710(10)Å b=7.3420(7)Å c=26.306(2)Å
α=90° β=94.540(8)° γ=90°
<i>N</i>-{[4-(3-phenyl-4-sydnonylideneamino)-5-sulfanylidene-1<i>H</i>-1,2,4-triazol-3-yl]methyl}benzamide ethanol monosolvate
C19H15N7O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 7 1057-1061
a=8.6313(6)Å b=10.8378(9)Å c=13.3840(10)Å
α=66.645(8)° β=79.287(8)° γ=85.151(8)°
<i>N</i>-({4-[3-(4-Methylphenyl)-4-sydnonylideneamino]-5-sulfanylidene-1<i>H</i>-1,2,4-triazol-3-yl}methyl)benzamide ethanol monosolvate
C20H17N7O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 7 1057-1061
a=8.5631(5)Å b=11.1242(8)Å c=13.5632(9)Å
α=70.244(6)° β=76.086(7)° γ=84.058(6)°
4-(4-Fluorophenyl)piperazin-1-ium 2-hydroxy-3,5-dinitrobenzoate
C10H14FN2,C7H3N2O7
Acta Crystallographica Section E (2020) 76, 6 841-847
a=10.6829(6)Å b=13.1701(6)Å c=13.5563(7)Å
α=90° β=108.970(5)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium hydrogen oxalate
C10H14FN2,C2HO4
Acta Crystallographica Section E (2020) 76, 6 841-847
a=17.0606(6)Å b=5.7820(2)Å c=12.5815(5)Å
α=90° β=102.761(4)° γ=90°
4-(4-Fluorophenyl)piperazin-1-ium hydrogen (2<i>R</i>,3<i>R</i>)-tartrate monohydrate
C10H14FN2,C4H5O6,H2O
Acta Crystallographica Section E (2020) 76, 6 841-847
a=7.0961(4)Å b=7.4967(4)Å c=30.757(2)Å
α=90° β=90° γ=90°
3-[5-(2-Chlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl]-1-[4-(prop-2-yn-1-yloxy)phenyl]prop-2-en-1-one
C28H21ClN2O3
Acta Crystallographica Section E (2020) 76, 5 683-691
a=9.909(7)Å b=10.193(6)Å c=12.024(8)Å
α=90.94(2)° β=106.27(2)° γ=92.75(2)°
3-[5-(4-Chlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl]-1-[4-(prop-2-yn-1-yloxy)phenyl]prop-2-en-1-one
C28H21ClN2O3
Acta Crystallographica Section E (2020) 76, 5 683-691
a=8.9959(14)Å b=9.7380(15)Å c=13.637(2)Å
α=95.901(4)° β=94.122(4)° γ=95.959(4)°
3-[3-Methyl-5-(naphthalen-2-yloxy)-1-phenyl-1<i>H</i>-pyrazol-4-yl]-1-[4-(prop-2-ynyloxy)phenyl]prop-2-en-1-one
C32H24N2O3
Acta Crystallographica Section E (2020) 76, 5 683-691
a=8.8615(6)Å b=10.4973(7)Å c=13.6588(10)Å
α=79.006(3)° β=89.412(3)° γ=80.971(3)°
1-(4-Azidophenyl)-3-[3-methyl-5-(2-methylphenoxy)-1-phenyl-1<i>H</i>-pyrazol-4-yl]prop-2-en-1-one
C26H21N5O2
Acta Crystallographica Section E (2020) 76, 5 683-691
a=9.8432(6)Å b=11.7441(7)Å c=12.3005(7)Å
α=114.120(2)° β=111.139(2)° γ=96.537(2)°